Medcura, Inc. is a commercial-stage medical device company developing versatile hemostatic products serving large surgical, medical and consumer market opportunities. The Company's proprietary technology platform combines the use of safe, inert ingredients with patented chemistries, all aimed at introducing disruptively lower-cost products capable of safely and effectively controlling bleeding across a broad spectrum of clinical applications. Learn more about Medcura's growing product line at www.medcurainc.com.